mechanism 1,702 words KG: ent-gene-961a77ee
Contents

APP/PS1 Double Transgenic Mouse Model

🔬 Protein Info
Gene Symbolent-gene-961a77ee
Primary ExpressionHigh-level expression in neurons throughout the brain [@radde2006]
Locationtransmembrane domain II of PS1 ( residue M146)
EffectSubtle alteration of γ-secretase substrate specificity
OriginOne of the most common FAD PSEN1 mutations, first identified in families with early-onset AD
Aβ elevation3-5 fold increase in total Aβ production [@moechars1999]
ResultShifts Aβ production toward the more aggregation-prone Aβ42 species
InheritanceAutosomal dominant, early-onset familial AD [@borchelt1996]
Aβ shiftIncreases Aβ42/Aβ40 ratio (~2-3 fold)
Pathology onsetSimilar to PS1ΔE9, plaques detectable by 5-8 months
Co-integrationBoth transgenes integrated on separate chromosomes
PromoterMouse prion protein (PrP) promoter drives neuronal expression
BackgroundC57BL/6J x C3H hybrid background
OnsetPlaques detectable by 6 months of age
DistributionCortex and hippocampus first, spreading to striatum later
Plaque typesBoth diffuse and neuritic (cored) plaques
KG Connections21 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (26)

Synaptic Vesicle Tau Capture Inhibition
Score: 0.58
Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.56
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Lysosomal Membrane Repair Enhancement
Score: 0.54
Cryptic Exon Silencing Restoration
Score: 0.53
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
← Prevpg 2/2

Related Analyses (30)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (24)

Plasma ATN biomarkers across AD continuum in Chilean cohort
clinical · proposed · Score: 0.95
Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90
Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90
Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's diseas
validation · proposed · Score: 0.95
Anti-ASC antibody intracerebroventricular injection in APP/P
validation · proposed · Score: 0.95

Knowledge Graph (12 edges)

ent-gene-961a77ee has_risk_variant multiple
ent-gene-961a77ee participates_in_pathway R-HSA-933542
ent-gene-961a77ee participates_in_pathway R-HSA-879415
ent-gene-961a77ee participates_in_pathway R-HSA-977225
ent-gene-961a77ee participates_in_pathway R-HSA-9936686
ent-gene-961a77ee participates_in_pathway R-HSA-9936900
ent-gene-961a77ee participates_in_pathway R-HSA-3000178
ent-gene-961a77ee participates_in_pathway R-HSA-8862803
ent-gene-961a77ee participates_in_pathway R-HSA-9660826
ent-gene-961a77ee participates_in_pathway R-HSA-844456

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.